Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the full record of transactions filed by Said Darwazah. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 14 reports have been logged. Activity tracked since 31 May 2024. The latest transaction was filed on 19 December 2025 (Grant). Regulator: RNS (LSE). All data is openly available.
Companies and markets linked to Said Darwazah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Said Darwazah has 14 filings in total. In the 14 sampled recent filings, all tied to Hikma Pharmaceuticals PLC, buys total EUR 2311501 and sells total EUR 0, over the period from 2024-03-13 to 2026-06-05. The modal transaction nature is Grant, and no primary role is provided, although one filing lists him at Hikma Pharmaceuticals PLC as Chief Executive Officer.